… Gehrig's disease - treatments and investigational drugs Amyotrophic lateral sclerosis (ALS) …
[1] Amyotrophic lateral sclerosis gained notoriety after the New York Yankee baseball player…

… Amyotrophic lateral sclerosis (ALS) is a progressive disease for which there are currently
no significant treatments to … and treatment. There have been many advances in symptomatic …

… supported by preclinical efficacy data for the treatment of afflictions to the CNS. … therapeutic.
This article discusses the rationale for cell-based therapy in amyotrophic lateral sclerosis and …

… therapy that would prevent or cure a disease. Modern therapeutic strategies comprise of
neuroprotective treatment … later become known as an amyotrophic lateral sclerosis (ALS). He …

… Amyotrophic lateral sclerosis (ALS) is a neurodegenerative … Patients with amyotrophic
lateral sclerosis (ALS) may have a … Current treatments only have a small effect on progression, …

… of neurodegenerative drug therapy is littered with the carcasses of failed drug trials. This …
from ‘bench to bedside’. There are several imminent programs that I am particularly proud of. …

… with Amyotrophic Lateral Sclerosis, the … Amyotrophic Lateral Sclerosis experienced that
treatment with MI-E was exhausting and inefficient. Despite adjustments of settings, all treatment …

… Moving stem cells research from bench to bedside requires a thorough knowledge of
their … of unproven treatments to patients outside clinical trial and drug agencies’ approval [43]. …

… in the non-pharmacological therapy trials in ALS. Currently, no therapeutic effort seems to
be … , but recent findings in ALS will certainly help in the discovery of an effective treatment. …

… therapeutic target in amyotrophic lateral sclerosis (ALS). Lithium has known neuroprotective
properties and is an inducer of autophagy. Treatment of ALS … ’ of the pharmacological effects …